Admission Date:  [**2178-5-13**]       Discharge Date:  [**2178-5-20**]  Date of Birth:   [**2103-5-16**]       Sex:  M  Service:  HISTORY OF PRESENT ILLNESS:  The patient is a 74 year old with known coronary artery disease about to undergo surgery for a pituitary adenoma for which he is being evaluated to undergo scheduled cardiac catheterization prior to his adenoma surgery.
Known pituitary adenoma, which will require surgery in the future.
In summary, the catheterization showed an ejection fraction of 55%, normal left main, left anterior descending artery with a mid segment total occlusion, distal filling from right to left collaterals, circumflex 60-70% tubular lesion with 99% distal OM-2 lesion, right coronary artery total occlusion except mid segment.
On [**5-13**], the patient was brought to the operating room for coronary artery bypass grafting.
In summary, the patient had an off-pump CABG x4 with LIMA to the LAD, saphenous vein graft to the LPL, saphenous vein graft to the PDA, and saphenous vein graft to the OM.
He tolerated the operation well.
At the time of transfer, the patient had Neo-Synephrine 1.5 mcg/kg/minute and propofol at 30 mcg/kg/minute.
He was weaned from the ventilator and successfully extubated on the morning of postoperative day one.
Basal artery and internal carotid arteries were patent.
Over the next two days, the patient was weaned from all cardioactive IV medications, and on postoperative day five, the patient was brought for a MRI which showed no acute vascular territorial infarction, a large intracellular, supracellular mass with a small focus of susceptibility of infarct consistent with hemorrhage and unchanged air fluid levels in the maxillary and sphenoid sinuses.
On postoperative day six, he was transferred to the floor for continuing postoperative care and cardiac rehabilitation.
Pravastatin 20 mg q day.
Plavix 75 mg q day.
Colace 100 mg [**Hospital1 **].
Percocet 1-2 tablets po q4h prn.
Ibuprofen 400 mg po q8h prn.
Prednisone 7.5 mg x1 day, then decreased to 5 mg x1 day, then 2.5 mg x2 days, then discontinue.
Coronary artery disease status post coronary artery bypass grafting x4.
